Bright Minds Biosciences, Inc. (DRUG)
20.75
+1.79
(+9.44%)
USD |
NASDAQ |
Nov 05, 16:00
20.76
+0.01
(+0.05%)
After-Hours: 20:00
Bright Minds Biosciences Market Cap : 204.68M for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2026 | 187.02M |
| November 03, 2026 | 212.57M |
| November 02, 2026 | 258.44M |
| October 30, 2026 | 542.33M |
| October 29, 2026 | 559.20M |
| October 28, 2026 | 545.68M |
| October 27, 2026 | 532.86M |
| October 26, 2026 | 503.96M |
| October 23, 2026 | 517.67M |
| October 22, 2026 | 519.74M |
| October 21, 2026 | 497.55M |
| October 20, 2026 | 544.50M |
| October 19, 2026 | 530.89M |
| October 16, 2026 | 506.03M |
| October 15, 2026 | 534.73M |
| October 14, 2026 | 500.21M |
| October 13, 2026 | 506.62M |
| October 12, 2026 | 532.76M |
| October 09, 2026 | 533.15M |
| October 08, 2026 | 512.93M |
| October 07, 2026 | 512.93M |
| October 06, 2026 | 475.94M |
| October 05, 2026 | 491.13M |
| October 02, 2026 | 500.01M |
| October 01, 2026 | 485.41M |
| Date | Value |
|---|---|
| September 30, 2026 | 491.43M |
| September 29, 2026 | 490.64M |
| September 28, 2026 | 509.58M |
| September 25, 2026 | 510.96M |
| September 24, 2026 | 527.83M |
| September 23, 2026 | 571.33M |
| September 22, 2026 | 598.45M |
| September 21, 2026 | 586.52M |
| September 18, 2026 | 601.51M |
| September 17, 2026 | 607.14M |
| September 16, 2026 | 583.07M |
| September 15, 2026 | 594.02M |
| September 14, 2026 | 625.19M |
| September 11, 2026 | 623.21M |
| September 10, 2026 | 641.17M |
| September 09, 2026 | 641.76M |
| September 08, 2026 | 660.01M |
| September 04, 2026 | 642.74M |
| September 03, 2026 | 670.96M |
| September 02, 2026 | 701.53M |
| September 01, 2026 | 698.77M |
| August 31, 2026 | 707.55M |
| August 28, 2026 | 718.21M |
| August 27, 2026 | 735.22M |
| August 26, 2026 | 755.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 248.87B |
| Lineage Cell Therapeutics, Inc. | 248.46M |
| Recursion Pharmaceuticals, Inc. | 1.958B |
| Agenus, Inc. | 273.59M |
| Anika Therapeutics, Inc. | 258.22M |
Market Cap Related Metrics
| PEG Ratio | -0.0828 |
| Price to Book Value | 0.9435 |
| Price | 20.75 |
| Earnings Yield | -10.04% |
| PEGY Ratio | -0.0828 |